SCHEMBL845237

SCHEMBL845237

Cn1cccc1CC(=O)N1CCC[C@H]1C(=O)Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)Cc3cccn3C)cc2)cc1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
PABPC1 P11940 1/20 0.44
MAPK1 P28482 2/20 0.44
HTT P42858 1/20 0.44
HCRTR1 O43613 2/20 0.43
HCRTR2 O43614 2/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
NPC1 O15118 1/20 0.42
LMNA P02545 2/20 0.42
GAA P10253 1/20 0.42
KDM4E B2RXH2 1/20 0.42
EP300 Q09472 2/20 0.41
CREBBP Q92793 2/20 0.41
ITGB1 P05556 1/20 0.41
ITGA4 P13612 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL845877 0.93 ALDH1A1 (0.40) ALDH1A1CYP2C9CYP2C19PABPC1MAPK1
SCHEMBL845282 0.83 CYP2C9 (0.47) ALDH1A1CYP2C9CYP2C19PABPC1MAPK1
SCHEMBL15116912 0.83 ALDH1A1 (0.56) ALDH1A1CYP2C9CYP2C19PABPC1MAPK1
SCHEMBL845111 0.83 ALDH1A1 (0.56) ALDH1A1CYP2C9CYP2C19PABPC1MAPK1
SCHEMBL13272444 0.83 ALDH1A1 (0.56) ALDH1A1CYP2C9CYP2C19PABPC1MAPK1
SCHEMBL845226 0.83 ALDH1A1 (0.56) ALDH1A1CYP2C9CYP2C19PABPC1MAPK1
SCHEMBL1030175 0.83 ALDH1A1 (0.56) ALDH1A1CYP2C9CYP2C19PABPC1MAPK1
SCHEMBL845205 0.83 ALDH1A1 (0.56) ALDH1A1CYP2C9CYP2C19PABPC1MAPK1
SCHEMBL845251 0.82 PABPC1 (0.50) ALDH1A1CYP2C9CYP2C19PABPC1MAPK1
SCHEMBL14648036 0.81 HCRTR1 (0.44) ALDH1A1CYP2C9CYP2C19PABPC1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed